Share
Journal Information
Issue
Vol. 36. Issue 2.Pages 51-100 (March - April 2024)
Originales
Evaluation of the relationship between atherosclerosis and Helicobacter pylori infection with measurement of growth differentiation factor 15 and atherosclerosis indicators in adults with no comorbidity
Osman Başpinar, Ayça Elibol, Derya Koçer, Turgut Tursem Tokmak, Serkan Doğan, Oğuzhan Sıtkı Dizdar
Clin Invest Arterioscl. 2024;36:51-9
High-fat diet promotes coagulation and endothelial activation in Sprague Dawley rats: Short-term effects of combined oral contraceptives
Oyesanmi A. Fabunmi, Phiwayinkosi V. Dludla, Bongani B. Nkambule
Clin Invest Arterioscl. 2024;36:60-70
Influencia de la concentración de triglicéridos en la lipoproteína(a) en función de la dislipidemia
Victoria Marco-Benedí, Ana Cenarro, Martín Laclaustra, Pilar Calmarza, Ana M. Bea, Àlex Vila, Carlos Morillas-Ariño, José Puzo, ... Fernando Civeira
Clin Invest Arterioscl. 2024;36:71-7
Full text access
Open Article
Editorial
Is Helicobacter pylori a new kid on the block?
Manuel Vázquez-Carrera
Clin Invest Arterioscl. 2024;36:78-9
Artículo especial
Prevención cardiovascular en la diabetes mellitus. ¿Es adecuado hablar de riesgo moderado o intermedio?
Sergio Martínez-Hervás, José T. Real, Rafael Carmena, Juan F. Ascaso
Clin Invest Arterioscl. 2024;36:80-5
Full text access
Open Article
Revisión
Effectiveness and safety of injectable PCSK9 inhibitors in dyslipidaemias’ treatment and cardiovascular disease prevention: An overview of 86 systematic reviews and a network metaanalysis
Konstantinos Pamporis, Paschalis Karakasis, Spyridon Simantiris, Marios Sagris, Konstantinos I. Bougioukas, Nikolaos Fragakis, Dimitrios Tousoulis
Clin Invest Arterioscl. 2024;36:86-100